Further mechanism study demonstrated that the level of TGF-β1-producing DN T cells and immune activation had a negative correlation after ART. Taken together, our study suggests that DN T cells control the immunological response in HIV-1-infected patients. These findings expand our understanding of the mechanism of immune reconstitution and could develop specific treatments to return the immune system to homeostasis following initiation of HIV-1 therapy.
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CD4
− CD8 − double-negative (DN) T cells constitute approximately 1-5% of T lymphocytes in mice, non-human primates, and humans (1) (2) (3) (4) . These cells are also found in the lymph nodes, lungs, and gut-associated lymphoid tissues (5) (6) (7) (8) . They predominately have the memory phenotype (9) , and it has been suggested that they play an important function in graft-vs.-host disease (10), autoimmune diseases (11), parasite infection (12) , and infectious disease, such as HIV/SIV infection (5, 9, (13) (14) (15) also secrete CD4-like cytokines (IL-4, IL-17, IFN-γ, and TNF-α) to exert their T helper function (4, 5, 12, 16, 17) . In SIV-infected natural hosts, such as sooty mangabeys and African green monkeys, the frequency of DN T cells is about 10-40% of the total circulating lymphocytes (4). The maintenance of high numbers of these DN T cells capable of secreting T helper cytokines is associated with immune activation, and thus it is proposed that this can contribute to the prevention of SIV disease progression in natural host monkey species (4, 5, 9) . In primary HIV-1-infected individuals, elevated DN T cells are associated with the control of immune activation and lower viral load (14) . In addition to secreting IL-10 and TGF-β cytokine (14) , DN T cells are also involved in restraining the CD8 + T cell immune activation during primary HIV-1 infection (14) . During the chronic phase, a decrease of DN T cells is correlated with rapid disease progression (13) . Moreover, recently, DN T cells were identified as the latent HIV-1 reservoir that harbors HIV-1 Gag protein in the presence of antiretroviral therapy (ART) (18) .
Nearly 20-30% of the HIV-1-infected patients lack the ability to fully recover CD4 + T cells after long-term ART (19, 20) . These patients are considered as immunological non-responders (INRs). The failure of immune reconstitution eventually leads to the progression of AIDS or non-AIDS events, thereby increasing the morbidity and mortality in HIV/AIDS patients (21, 22) . The underlying causes associated with INRs are age, low nadir CD4, high immune activation, and impaired thymus function (23) (24) (25) .
The role of DN T cells in immune reconstitution has not been investigated. In the present study, the distribution of DN T cells and CD38
+ HLA-DR + CD8 + T cells as marker of immune activation was assessed in immunological responders (IRs) vs. INRs after prolonged ART in HIV-1 chronically infected patients. We found a higher number of DN T cells to be associated with a decreased number of CD38 + HLA-DR + CD8 + T cells in IRs patients, suggesting that DN T cells play a role in immune restoration. Moreover, the production of TGF-β1 by DN T cells might participate in the downregulation of immune activation after long-term ART.
MaTerials anD MeThODs study subjects and ethical issues
Cryo-preserved peripheral blood mononuclear cells (PBMCs) were obtained from ART-treated chronic HIV-1-infected cohorts present in Beijing You'an Hospital. HIV-1 patients received ART for at least 1 year post-infection, and their CD4 + T cell count had dropped below 350 cells/μl. These patients were divided into two groups following a minimum of 2 years of ART: 17 IRs (CD4 > 500 cells/μl) and 19 immunological non-responders (INRs, CD4 < 350 cells/μl). Eighteen age-matched healthy controls (HCs) were also included in this study. All the participants provided written informed consent. This study and all relevant experiments have been approved by the Beijing You'an Hospital Research Ethics Committee. The methods were carried out in accordance with the approved guidelines and regulations.
immunophenotyping Cryo-preserved PBMCs were thawed in RPMI 1640 medium (Invitrogen, Carlsbad, CA, USA); then, these cells were washed with PBS containing 1% BSA. Briefly, cells were incubated at room temperature for 20 min with the cell viability marker fixable viability stain 510 (BD Biosciences, San Diego, CA, USA) and the following monoclonal conjugated antibodies: CD3-PE-cy7 (SK7), CD4-APC-cy7 (SK3), CD8-PE (RPA-T8), CD8-percp-cy5.5 (RPA-T8), HLA-DR-APC (TU36), and CD38-PE (HIT2) (BD Biosciences). Cells were washed and fixed with 2% paraformaldehyde, and at least 50,000 live lymphocytes were acquired with a BD FACSCanto II Flow Cytometry Analyzer Systems (BD Biosciences). Forward angle and side scatter light gating were used to exclude cell debris from the analysis. Forward width and forward area were used to exclude doublet cells. The final analysis was performed using the Flowjo7.6.1 software (Tree Star Inc., Ashland, OR, USA).
intracellular cytokine staining
Peripheral blood mononuclear cells (1 × 10 6 ) were stimulated with PMA (500 ng/ml), ionomycin (2 μg/ml), and brefeldin A (10 μg/ml) for 5 h at 37°C in 5% CO2. The surface were stained with CD3-BV421 (UCHT1), CD8-percp-cy5.5 (RPA-T8), and CD4-FITC (RPA-T4) (BD Biosciences), and intracellular staining was performed using anti-IL-17A-PE (N49-653), IL-10-APC (JES3-19F1) (BD Biosciences), IL-4-APC (8D4-8), TGF-β1-PE (TW4-6H10), TNF-α-PE-cy7 (MAb11), and IFN-γ-PE-cy7 (4S. B3) (Biolegend, San Diego, CA, USA) and the foxp3/transcription factor staining buffer set (eBioscience, San Diego, CA, USA) according to the manufacturer's protocols. Unstimulated cells were used as a negative control.
cD4
+ T cell count and Viral load Measurement
Routine blood CD4
+ T cell counts (cells per microliter) were measured by four-color flow cytometry using human CD45 + , CD3
+ , CD4 + , and CD8 + cell markers (BD Biosciences) in whole peripheral blood samples from each patient using FACS lysing solution (BD Biosciences) according to the manufacturer's instructions. Plasma HIV-1 viral load (copies per milliliter of plasma) was quantified by real-time PCR (Abbort, Des Plaines, IL, USA). The sensitivity of viral RNA detection using this assay is 40 copies/ml of plasma.
statistical analysis
All statistical analyses were performed using the GraphPad Prism software v5.0 (GraphPad Software, Inc., La Jolla, CA, USA). The statistical significance between two groups was calculated using Mann-Whitney U test, and correlations were determined by the Spearman rank correlation test, with r being the Spearman correlation coefficient. The p < 0.05 was considered statistically significant.
resUlTs characterization of the subjects
Thirty-six HIV-1-infected patients who had sustained undetectable viral load after treatment were divided into two groups: IRs (n = 17) and INRs (n = 19) according to their CD4 + T cell level recorded after at least 2 years of treatment. Eighteen age-matched HCs were also part of this study ( Table 1) . These HIV-1-infected patients had no HBV or HCV co-infection. The plasma HIV-1 viral load between IR and INR groups did not show any statistically significant difference before ART. The frequencies of CD4 + T cells also did not differ significantly in these two groups of patients, before or after ART, respectively. However, CD4 + T cell count in IR group patients was higher than in INR group patients (p = 0.002 before ART; p < 0.0001 after ART) and reached the level of HCs after ART administration. (Figures 2A,B) but not with viral load (Figures 2C,D) .
long-term arT

inrs with Poor Dn T cell restoration after arT Display higher immune activation
The regulatory function of DN T cells is responsible for limiting the immune activation in HIV/SIV infection (5, 14) . Therefore, we next determined the relationship between DN T cells and the level of immune activation in immune reconstitution. Co-expression of CD38 and HLA-DR on the surface of CD8 + T cells was used as a marker to evaluate the degree of immune activation. Compared to HCs, both IRs and INRs showed a significant increased level of CD38 + HLA-DR + CD8 + T cells during chronic HIV-1 infection (p < 0.0001) (Figure 3A) . Although the long-term ART effectively reduced the overall immune activation among patients from both groups, the INR group displayed a higher level of CD38 and HLA-DR expression on CD8 + T cells in comparison to IRs (p < 0.05, Figure 3A) . We next analyzed the relationship between immune activation and DN T cells in patients pre-or post-ART, respectively. We observed a significant negative correlation between the count of DN T cells and the level of CD38
+ T cells in patients after long-term ART (Figures 3B-E) . pro-inflammatory (TNF-α) cytokine producing by DN T cells. As shown in Figure 4A , in contrast to CD4 + T cells, the TGF-β1 expressing DN T cells were detected in HIV-1 patients. In HCs, the expression of TGF-β1 by DN T cells was similar to that of unstimulated cells. The production of TGF-β1 in DN T cells was significantly unregulated after ART in IRs (p < 0.05); however, this increasing trend was not observed in INRs (Figure 4B) . Furthermore, the level of TGF-β1-secreting DN T cells in IRs was much higher than that in INRs after ART (p < 0.05) (Figure 4B ).
Correlation analysis revealed that the proportion of TGF-β1 in DN T cells was negatively correlated with the level of immune activation after prolonged ART but not pre-ART in HIV-1 patients (Figures 4C,D) . Several studies have demonstrated that a high level of DN T cells is associated with a non-pathogenic outcome in SIV host species (4, 5, 9) . Consistent with the SIV study, we have previously observed a decrease in the number of DN T cells in CD4 low HIV-1 patients (13) . The INRs typically have a higher risk of opportunistic infections like AIDS or non-AIDS events than IRs and display increased morbidity and mortality (22) . INRs and IRs have similar CD4
+ T cell counts but the abnormal CD4 + T cell function may influence the outcome of antiviral immune responses (26) . The DN T cells may compensate for the CD4 + T cells, therefore, poor restoration of these DN T cells in INRs (Figures 1B,C) may result in impaired immune responses during HIV-1 infection and thus accelerate the disease progression among these patients despite the fact that they have similar CD4
+ T cell counts. Furthermore, the size and position of latent HIV-1 infection resulted in different progression in HIV-1 patients (27) (28) (29) . HIV-1 latent reservoir was identified in DN T cells (18) , therefore, we proposed that provirus harbored in DN T cells also contributes to the immune reconstitution failure in INRs.
The regulatory role of DN T cells has been demonstrated in HIV/SIV infection (5, 14) . In SIV-infected sooty mangabeys, a lack of disease progression correlates with significant CD4 + T cell loss and is associated with DN T cells (5) . These mangabeys exhibited low levels of immune activation, and the presence of DN T cells was believed to be responsible for this control (5) . In primary HIV-1-infected individuals, elevated DN T cells were associated with the control of immune activation and lower viral load (14) . The production of IL-10 and TGF-β1 by DN T cells has been suggested to participate to this outcome, which further supports the regulatory role of DN T cells (14) . Consistent with these studies, we confirmed that INRs had higher immune activation than IRs after long-term ART, although ART resulted in an overall reduction in the immune activation as shown in Figure 3A . Moreover, we observed a negative correlation between DN T cells and the level of immune activation in HIV-1 patients after ART ( Figure 3E) . A high level of immune activation was previously proposed to contribute to the failure of immune reconstitution (23, 24) . Further analysis revealed that the secretion of TGF-β1 by DN T cells was responsible for the control of immune activation after long-term ART (Figure 4) . As we found that DN T cells were increased in IR patients, our results put forward the potential contribution of DN T cells in the process of immune reconstitution in HIV-1-infected patients.
In conclusion, our study demonstrated that INRs have lower levels of DN T cells and exhibit higher immune activation than IRs after long-term ART. Because DN T cells have both CD4-like and regulatory functions, the DN T cells in IRs may result in partial compensation of CD4 + T cell loss and in the control of immune activation, thereby improving the immunological response to ART in IRs.
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FigUre s1 | recovery of double-negative (Dn) T cells in hiV-infected patients after long-term antiretroviral therapy (arT). Healthy control (n = 18) and chronic HIV-infected patients (n = 36) were recruited in this study. Fresh blood of patients was collected before and after ART; peripheral blood mononuclear cells were isolated and stored at liquid nitrogen. Flow cytometry was performed as described in methods and materials. Frequency (a) and count (b) of DN T cells are compared among three groups. Mann-Whitney U test was used for statistical analysis. Horizontal lines indicate mean values, and error bars represent mean ± SEM (***p < 0.0001).
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